Exploratory Analysis of the Impact of a Single Dose of Trastuzumab on the Immune Microenvironment in HER2-Positive Early-Stage Breast Cancer.

Saved in:
Bibliographic Details
Title: Exploratory Analysis of the Impact of a Single Dose of Trastuzumab on the Immune Microenvironment in HER2-Positive Early-Stage Breast Cancer.
Authors: Bastin N; School of Medicine, Vanderbilt University, Nashville, TN 37232, USA.; Department of Medicine, Medical Center, Vanderbilt University, Nashville, TN 37232, USA., Mezzanotte-Sharpe J; Department of Medicine, Medical Center, Vanderbilt University, Nashville, TN 37232, USA., Alvarez R; Department of Pathology, University of Washington, Seattle, WA 98195, USA., Partridge SC; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Radiology, University of Washington, Seattle, WA 98195, USA., Dintzis SM; Department of Pathology, University of Washington, Seattle, WA 98195, USA.; Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Stanton SE; Cancer Immunoprevention Laboratory, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR 97213, USA., Gadi VK; Division of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60612, USA.; Translational Oncology Program, University of Illinois Cancer Center, Chicago, IL 60612, USA., Kennedy LC; Department of Medicine, Medical Center, Vanderbilt University, Nashville, TN 37232, USA.
Source: Biomedicines [Biomedicines] 2025 Nov 14; Vol. 13 (11). Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2227-9059
DOI:10.3390/biomedicines13112784